ACADIA Pharmaceuticals Inc (ACAD)
16.39
-0.20
(-1.21%)
USD |
NASDAQ |
Apr 25, 13:07
ACADIA Pharmaceuticals Free Cash Flow (Quarterly): 85.39M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.39M |
| September 30, 2023 | -59.00M |
| June 30, 2023 | -31.80M |
| March 31, 2023 | -17.93M |
| December 31, 2022 | -23.85M |
| September 30, 2022 | -0.727M |
| June 30, 2022 | -13.12M |
| March 31, 2022 | -76.33M |
| December 31, 2021 | -23.12M |
| September 30, 2021 | -17.06M |
| June 30, 2021 | -25.37M |
| March 31, 2021 | -61.22M |
| December 31, 2020 | -29.49M |
| September 30, 2020 | -24.51M |
| June 30, 2020 | -39.82M |
| March 31, 2020 | -49.94M |
| December 31, 2019 | -29.91M |
| September 30, 2019 | -18.93M |
| June 30, 2019 | -38.42M |
| March 31, 2019 | -65.00M |
| December 31, 2018 | -39.60M |
| September 30, 2018 | -43.30M |
| June 30, 2018 | -40.99M |
| March 31, 2018 | -45.68M |
| December 31, 2017 | -29.90M |
| Date | Value |
|---|---|
| September 30, 2017 | -58.46M |
| June 30, 2017 | -59.16M |
| March 31, 2017 | -71.05M |
| December 31, 2016 | -61.44M |
| September 30, 2016 | -49.73M |
| June 30, 2016 | -65.32M |
| March 31, 2016 | -41.42M |
| December 31, 2015 | -35.02M |
| September 30, 2015 | -32.04M |
| June 30, 2015 | -30.55M |
| March 31, 2015 | -26.33M |
| December 31, 2014 | -17.90M |
| September 30, 2014 | -17.56M |
| June 30, 2014 | -16.97M |
| March 31, 2014 | -14.19M |
| December 31, 2013 | -10.39M |
| September 30, 2013 | -9.891M |
| June 30, 2013 | -5.518M |
| March 31, 2013 | -6.585M |
| December 31, 2012 | -6.297M |
| September 30, 2012 | -5.306M |
| June 30, 2012 | -4.80M |
| March 31, 2012 | -5.23M |
| December 31, 2011 | -5.338M |
| September 30, 2011 | -4.175M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-76.33M
Minimum
Mar 2022
85.39M
Maximum
Dec 2023
-26.06M
Average
-25.37M
Median
Jun 2021
Free Cash Flow (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | -22.78M |
| Amylyx Pharmaceuticals Inc | 13.20M |
| Regulus Therapeutics Inc | -6.196M |
| Minerva Neurosciences Inc | -5.991M |
| Viking Therapeutics Inc | -17.64M |